(Q37375835)

20 August 2017

1 reference

title

Ursodeoxycholic acid in chronic liver disease (English)

1 reference

20 August 2017

chronic liver disease

0 references

author name string

de Caestecker JS

1

1 reference

20 August 2017

Jazrawi RP

2

1 reference

20 August 2017

Petroni ML

3

1 reference

20 August 2017

Northfield TC

4

1 reference

20 August 2017

language of work or name

English

0 references

publication date

1 September 1991

1 reference

20 August 2017

1 reference

20 August 2017

32

1 reference

20 August 2017

9

1 reference

20 August 2017

1061-1065

1 reference

Bile acid glycine and taurine conjugates in serum of patients with primary biliary cirrhosis: effect of ursodeoxycholic treatment

20 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1379051

Medical treatment of primary biliary cirrhosis

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1379051

Ursodeoxycholic acid-induced changes of plasma and urinary bile acids in patients with primary biliary cirrhosis

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1379051

Effects of ursodeoxycholic acid treatment on nutrition and liver function in patients with cystic fibrosis and longstanding cholestasis

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1379051

Gallstone dissolution with ursodeoxycholic acid in patients with chronic active hepatitis and two years follow-up. A pilot study

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1379051

Solubilization of lipids from hamster bile-canalicular and contiguous membranes and from human erythrocyte membranes by conjugated bile salts

26 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1379051

A randomized clinical trial of oral ursodeoxycholic acid in obstructive jaundice.

26 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1379051

Effect of ursodeoxycholic acid on bile acid metabolism in primary biliary cirrhosis.

26 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1379051

Effect of ursodeoxycholic acid treatment on alanine aminotransferase and gamma-glutamyltranspeptidase serum levels in patients with hypertransaminasemia. Results from a double-blind controlled trial

26 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1379051

Effect of different doses of ursodeoxycholic acid in chronic liver disease

2 September 2018

1 reference

12 December 2020

Treatment with ursodeoxycholic acid renders children with biliary atresia suitable for liver transplantation

1 reference

12 December 2020

Ursodeoxycholic acid for the treatment of primary biliary cirrhosis. Interim analysis of a double-blind multicentre randomized trial. The UDCA-PBC Study Group.

1 reference

12 December 2020

Ursodeoxycholic acid for primary sclerosing cholangitis

1 reference

12 December 2020

Improvement of biliary enzyme levels and itching as a result of long-term administration of ursodeoxycholic acid in primary biliary cirrhosis

1 reference

12 December 2020

Update on primary biliary cirrhosis

1 reference

12 December 2020

Hepatic expression of class I and class II major histocompatibility complex molecules in primary biliary cirrhosis: effect of ursodeoxycholic acid

1 reference

12 December 2020

Diminished survival in asymptomatic primary biliary cirrhosis. A prospective study

1 reference

12 December 2020

Interactions between different bile salts in the biliary excretion of the rat

1 reference

12 December 2020

Is ursodeoxycholic acid an effective treatment for primary biliary cirrhosis?

1 reference

12 December 2020

Tauroursodeoxycholate prevents taurocholate induced cholestasis

1 reference

12 December 2020

Ursodeoxycholic acid therapy in the treatment of biliary atresia

1 reference

12 December 2020

Ursodeoxycholic acid in primary biliary cirrhosis

1 reference

12 December 2020

Ursodeoxycholic acid in primary biliary cirrhosis: results of a controlled double-blind trial

1 reference

12 December 2020

Treatment of patients with benign recurrent intrahepatic cholestasis

1 reference

12 December 2020

Deterioration of primary biliary cirrhosis during treatment with ursodeoxycholic acid

1 reference

12 December 2020

Ursodeoxycholic acid in biliary atresia

1 reference

12 December 2020

Ursodeoxycholic acid for primary biliary cirrhosis

1 reference

12 December 2020

Identifiers

DOI

10.1136/GUT.32.9.1061

1 reference

20 August 2017

1 reference

20 August 2017

1 reference